Tatva Chintan Pharma Chem Q4 Results
- BSE: 543321
- NSE: TATVA
- ISIN: INE0GK401011
- Sector: Chemical Manufacturing
BSE
822
-1.00 (-0.12%)
-1.00 (-0.12%)Volume1.11 K
Updated: Mon 25 Nov, 2024 | 15:28:49
NSE
825
0.40 (0.05%)
0.40 (0.05%)Volume14.92 K
Updated: Mon 25 Nov, 2024 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Tatva Chintan Pharma Chem Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 98.27 | 84.21 | -% | 124.51 | -% |
| Selling/ General/ Admin Expenses Total | 14.37 | 14.77 | -% | 10.32 | -% |
| Depreciation/ Amortization | 6.23 | 6.58 | -% | 2.53 | -% |
| Other Operating Expenses Total | 26.81 | 21.10 | -% | 22.90 | -% |
| Total Operating Expense | 88.89 | 79.80 | -% | 110.77 | -% |
| Operating Income | 9.38 | 4.41 | -% | 13.75 | -% |
| Net Income Before Taxes | 13.69 | 5.24 | -% | 7.81 | -% |
| Net Income | 9.61 | 3.45 | -% | 16.96 | -% |
| Diluted Normalized EPS | 4.11 | 1.48 | -% | 8.70 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST